Advertisement
Screener

Altamira Therapeutics Ltd. (CYTOF) Form 6-K: Report of foreign private issuer, 2017

Altamira Therapeutics Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2017-11-28: Form 6-K; Period of report 2017-11-28; Description FORM 6-K; Document dp83273_6k.htm.
  • 2017-10-16: Form 6-K; Period of report 2017-10-16; Description FORM 6-K; Document dp81633_6k.htm.
  • 2017-10-11: Form 6-K; Period of report 2017-10-11; Description FORM 6-K; Document dp81548_6k.htm.
  • 2017-09-28: Form 6-K; Period of report 2017-09-28; Description FORM 6-K; Document dp80951_6k.htm.
FiledFormPeriod of reportDescriptionDocument
2017-11-286-K2017-11-28FORM 6-Kdp83273_6k.htm
2017-10-166-K2017-10-16FORM 6-Kdp81633_6k.htm
2017-10-116-K2017-10-11FORM 6-Kdp81548_6k.htm
2017-09-286-K2017-09-28FORM 6-Kdp80951_6k.htm
2017-09-266-K2017-09-26FORM 6-Kdp80857_6k.htm
2017-08-246-K2017-08-24FORM 6-Kdp79762_6k.htm
2017-08-106-K2017-08-10FORM 6-Kdp79255_6k.htm
2017-05-116-K2017-05-09FORM 6-Kdp76038_6k.htm
2017-04-136-K2017-04-13FORM 6-Kdp75033_6k.htm
2017-03-316-K2017-03-31FORM 6-Kdp74616_6k.htm
2017-03-146-K2017-03-14FORM 6-Kdp73890_6k.htm
2017-02-216-K2017-02-21FORM 6-Kdp73083_6k.htm
2017-02-146-K2017-02-14FORM 6-Kdp72850_6k.htm
2017-02-036-K2017-02-03FORM 6-Kdp72618_6k.htm